The country will see a steady decline in new coronavirus cases through next March, according to a new analysis from the Covid-19 Scenario Modeling Hub, Rob Stein and Carmel Wroth report for NPR's "Shots"—a scenario that suggests the worst of the delta surge may be over.
New CDC research indicates that while both the Pfizer-BioNTech and Moderna Covid-19 vaccines remained effective against hospitalization over a four-month period, one of them appeared to be more durable than the other. Here's what you need to know about this vaccine "efficacy gap"—and what it may mean for the booster shot debate.
Hospitals in the United States are projected to lose billions in net income by the end of the year, according to a new report released by the American Hospital Association—and their financial struggles may worsen as Covid-19 cases and hospitalizations continue to surge.
FDA on Wednesday authorized booster shots of the Pfizer-BioNTech Covid-19 vaccine for adults 65 years and older and those who are at high risk of severe Covid-19, whether because of their health or their job. Here are the full details.
Due to recent surges in Covid-19 cases, many hospitals in the United States have been forced to delay "elective" and "nonessential" procedures again. But those labels sometimes refer to critical surgeries, prompting one medical sociologist to suggest a new way of describing certain procedures.
CMS on Friday released the final installment of the payment notice for 2022, with additional policies for health insurance issuers and the Health Insurance Marketplaces, in today's bite-sized hospital and health industry news from the District of Columbia, Maryland, and Washington.